HOW CAN WE HELP YOU? Call 1-800-TRY-CHOP
1 - 1 of 1
The goal of this observational study is to describe the safety and effectiveness of larotrectinib in patients with locally advanced or metastatic TRK fusion cancer for whom a decision to treat with larotrectinib has been made before enrollment.
Related PI: Theodore Laetsch, MD
Related Conditions: Pediatric Cancer, Soft Tissue Sarcomas, Central Nervous System Tumors, Oncology, Solid Tumors, Pediatric Solid Tumors, Pediatric Oncology